Two insurance companies are considering offering new policies designed for people who need treatment due to serious side effects of COVID-19 vaccines, the Financial Supervisory Commission said.
The insurers plan to offer the products to individuals, but they have not finalized the scope of coverage nor the size of premiums, Insurance Bureau Director-General Shih Chiung-hwa (施瓊華) told a meeting of the legislature’s Finance Committee in Taipei yesterday.
“Once they [the insurers] submit their applications to launch the new products, we will expedite the review process so that the products can be put on the market and become available for consumers faster, if they qualify,” Shih said.
Photo: CNA
She did not identify the insurance companies.
Shih’s remarks came after Chinese Nationalist Party (KMT) Legislator Lai Shyh-bao (賴士葆) asked the commission if there are existing insurance policies to help people deal with any adverse reactions to COVID-19 vaccines.
“According to my understanding, no insurance policies would cover the risks,” Lai said, adding that the commission should address the issue, as controversies might arise after more people receive COVID-19 jabs.
The issue would be important, as some countries have delayed the rollout of the AstraZeneca COVID-19 vaccine over reports of blood clots, he added.
Lai asked the commission if it was encouraging the public to receive vaccinations, as the planned insurance policies would protect them.
“We think the vaccines recommended by the Ministry of Health and Welfare should not be problematic, but if consumers want the [insurance] products, we would make them available,” commission Chairman Thomas Huang (黃天牧) said.
RUN IT BACK: A succesful first project working with hyperscalers to design chips encouraged MediaTek to start a second project, aiming to hit stride in 2028 MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it is engaging a second hyperscaler to help design artificial intelligence (AI) accelerators used in data centers following a similar project expected to generate revenue streams soon. The first AI accelerator project is to bring in US$1 billion revenue next year and several billion US dollars more in 2027, MediaTek chief executive officer Rick Tsai (蔡力行) told a virtual investor conference yesterday. The second AI accelerator project is expected to contribute to revenue beginning in 2028, Tsai said. MediaTek yesterday raised its revenue forecast for the global AI accelerator used
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has secured three construction permits for its plan to build a state-of-the-art A14 wafer fab in Taichung, and is likely to start construction soon, the Central Taiwan Science Park Bureau said yesterday. Speaking with CNA, Wang Chun-chieh (王俊傑), deputy director general of the science park bureau, said the world’s largest contract chipmaker has received three construction permits — one to build a fab to roll out sophisticated chips, another to build a central utility plant to provide water and electricity for the facility and the other to build three office buildings. With the three permits, TSMC
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
RSS